Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
KYNB holding history
Kyntra Bio, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KYNB overviewAll 13F holders of KYNBFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −32,502−100.0% | Sold out | Holders |
| Q4 2025 | 32,502 | $285.4K | <0.1% | −39,947−55.1% | Reduced | Holders |
| Q3 2025 | 72,449 | $887.5K | <0.1% | +149+0.2% | Added | Holders |
| Q2 2025 | 72,300 | $383.2K | <0.1% | −16,202−18.3% | ReducedConverted for a 1-for-25 split | Holders |
| Q1 2025 | 2,212,561 | $685.9K | <0.1% | +947,046+74.8% | Added | Holders |
| Q4 2024 | 1,265,515 | $670.7K | <0.1% | −179,327−12.4% | Reduced | Holders |
| Q3 2024 | 1,444,842 | $577.9K | <0.1% | +1,444,842 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −753,546−100.0% | Sold out | Holders |
| Q4 2022 | 753,546 | $12.1M | <0.1% | −6,441−0.8% | Reduced | Holders |
| Q3 2022 | 759,987 | $9.89M | <0.1% | +759,987 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −460,842−100.0% | Sold out | Holders |
| Q2 2021 | 460,842 | $12.3M | 0.1% | +460,842 | New | Holders |